• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SCMR 立场文件（2020 年）：心血管磁共振的临床适应证。

SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance.

机构信息

Department of Radiology, E.01.132, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.

Department of Radiology, University Hospitals Leuven, Leuven, Belgium.

出版信息

J Cardiovasc Magn Reson. 2020 Nov 9;22(1):76. doi: 10.1186/s12968-020-00682-4.

DOI:10.1186/s12968-020-00682-4
PMID:33161900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7649060/
Abstract

The Society for Cardiovascular Magnetic Resonance (SCMR) last published its comprehensive expert panel report of clinical indications for CMR in 2004. This new Consensus Panel report brings those indications up to date for 2020 and includes the very substantial increase in scanning techniques, clinical applicability and adoption of CMR worldwide. We have used a nearly identical grading system for indications as in 2004 to ensure comparability with the previous report but have added the presence of randomized controlled trials as evidence for level 1 indications. In addition to the text, tables of the consensus indication levels are included for rapid assimilation and illustrative figures of some key techniques are provided.

摘要

心血管磁共振学会（SCMR）最后一次发布其关于心血管磁共振临床适应证的综合专家小组报告是在 2004 年。本共识小组报告将这些适应证更新到 2020 年，并包括全球范围内扫描技术、临床适用性和采用心血管磁共振的大幅增加。我们使用了与 2004 年几乎相同的适应证分级系统，以确保与之前的报告具有可比性，但增加了随机对照试验作为 1 级适应证的证据。除了文本外，还包括了共识适应证水平的表格，以便快速吸收，并且提供了一些关键技术的说明性图片。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/202f76d91ce6/12968_2020_682_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/4f78becf9c69/12968_2020_682_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/56755b811a03/12968_2020_682_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/e13a2f4172ca/12968_2020_682_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/74e81e9d580f/12968_2020_682_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/1703cc389375/12968_2020_682_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/10f18f23e7fd/12968_2020_682_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/aa01f86e58dd/12968_2020_682_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/9d231cd46e27/12968_2020_682_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/ef02a31a2163/12968_2020_682_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/f24d9403ef9c/12968_2020_682_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/b58dcaec264c/12968_2020_682_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/00eee21d49dc/12968_2020_682_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/60953dc960b1/12968_2020_682_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/7d080a53d2e1/12968_2020_682_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/202f76d91ce6/12968_2020_682_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/4f78becf9c69/12968_2020_682_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/56755b811a03/12968_2020_682_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/e13a2f4172ca/12968_2020_682_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/74e81e9d580f/12968_2020_682_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/1703cc389375/12968_2020_682_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/10f18f23e7fd/12968_2020_682_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/aa01f86e58dd/12968_2020_682_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/9d231cd46e27/12968_2020_682_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/ef02a31a2163/12968_2020_682_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/f24d9403ef9c/12968_2020_682_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/b58dcaec264c/12968_2020_682_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/00eee21d49dc/12968_2020_682_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/60953dc960b1/12968_2020_682_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/7d080a53d2e1/12968_2020_682_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ff/7650154/202f76d91ce6/12968_2020_682_Fig15_HTML.jpg

相似文献

1
SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance.SCMR 立场文件（2020 年）：心血管磁共振的临床适应证。
J Cardiovasc Magn Reson. 2020 Nov 9;22(1):76. doi: 10.1186/s12968-020-00682-4.
2
Competency based curriculum for cardiovascular magnetic resonance: A position statement of the Society for Cardiovascular Magnetic Resonance.基于能力的心血管磁共振课程：心血管磁共振学会的立场声明。
J Cardiovasc Magn Reson. 2024 Summer;26(1):100006. doi: 10.1016/j.jocmr.2023.100006. Epub 2023 Dec 22.
3
The growth and evolution of cardiovascular magnetic resonance: a 20-year history of the Society for Cardiovascular Magnetic Resonance (SCMR) annual scientific sessions.心血管磁共振的发展与演进：心血管磁共振学会（SCMR）年度科学会议 20 年历程。
J Cardiovasc Magn Reson. 2018 Jan 31;20(1):8. doi: 10.1186/s12968-018-0429-z.
4
Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR).心血管磁共振在女性心血管疾病中的应用：来自心血管磁共振学会（SCMR）的立场声明。
J Cardiovasc Magn Reson. 2021 May 10;23(1):52. doi: 10.1186/s12968-021-00746-z.
5
Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update.标准化心血管磁共振成像（CMR）协议：2020 年更新。
J Cardiovasc Magn Reson. 2020 Feb 24;22(1):17. doi: 10.1186/s12968-020-00607-1.
6
Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification.心血管磁共振学会 (SCMR) 临床研究中 CMRI 终点的专家共识：第一部分——分析验证和临床资格认证。
J Cardiovasc Magn Reson. 2018 Sep 20;20(1):67. doi: 10.1186/s12968-018-0484-5.
7
ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging. A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group.美国心脏病学会基金会/美国放射学会/心血管计算机断层扫描学会/心血管磁共振学会/美国核医学学会/北美心血管影像学会/心血管造影和介入学会/介入放射学会2006年心脏计算机断层扫描和心脏磁共振成像适宜性标准。美国心脏病学会基金会质量战略方向委员会适宜性标准工作组报告。
J Am Coll Radiol. 2006 Oct;3(10):751-71. doi: 10.1016/j.jacr.2006.08.008.
8
Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update : Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing.心血管磁共振标准化图像解读和后处理 - 2020 年更新：心血管磁共振学会（SCMR）：标准化后处理董事会信托基金工作组。
J Cardiovasc Magn Reson. 2020 Mar 12;22(1):19. doi: 10.1186/s12968-020-00610-6.
9
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.ACCF/ACR/AHA/NASCI/SCMR 2010年心血管磁共振专家共识文件：美国心脏病学会基金会专家共识文件特别工作组报告
Circulation. 2010 Jun 8;121(22):2462-508. doi: 10.1161/CIR.0b013e3181d44a8f. Epub 2010 May 17.
10
Challenges and opportunities for early career medical professionals in cardiovascular magnetic resonance (CMR) imaging: a white paper from the Society for Cardiovascular Magnetic Resonance.心血管磁共振（CMR）成像领域中早期职业医疗专业人员的挑战与机遇：来自心血管磁共振学会的白皮书。
J Cardiovasc Magn Reson. 2023 Nov 16;25(1):65. doi: 10.1186/s12968-023-00968-3.

引用本文的文献

1
Serial cardiac magnetic resonance imaging to assess myocardial inflammation in PET-positive cardiac sarcoidosis under immunomodulatory therapy: a retrospective observational study.采用连续心脏磁共振成像评估免疫调节治疗下PET阳性心脏结节病的心肌炎症：一项回顾性观察研究。
BMJ Open. 2025 Aug 25;15(8):e098540. doi: 10.1136/bmjopen-2024-098540.
2
Effect of SGLT2 inhibitors on cardiac structure and function assessed by cardiac magnetic resonance: a systematic review and meta-analysis.通过心脏磁共振评估钠-葡萄糖协同转运蛋白2抑制剂对心脏结构和功能的影响：一项系统评价和荟萃分析
Cardiovasc Diabetol. 2025 Aug 21;24(1):345. doi: 10.1186/s12933-025-02904-4.
3

本文引用的文献

1
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.SARS-CoV-2 疫情意大年夜利中间爆发严重川崎病样病：一项不雅察性队列研究。
Lancet. 2020 Jun 6;395(10239):1771-1778. doi: 10.1016/S0140-6736(20)31103-X. Epub 2020 May 13.
2
Usefulness of Cardiac Magnetic Resonance for Recurrent Pericarditis.心脏磁共振在复发性心包炎中的应用价值。
Am J Cardiol. 2020 Jan 1;125(1):146-151. doi: 10.1016/j.amjcard.2019.09.026. Epub 2019 Oct 11.
3
The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease.
Automated adaptive detection and reconstruction of quiescent cardiac phases in free-running whole-heart acquisitions using Synchronicity Maps from PHysiological mOtioN In Cine (SYMPHONIC) MRI.
利用来自电影磁共振成像中生理运动同步映射（SYMPHONIC）的同步图，在自由运行的全心采集过程中自动自适应检测和重建静态心脏相位。
MAGMA. 2025 Aug 19. doi: 10.1007/s10334-025-01289-5.
4
Evaluation of subclinical myocardial involvement in systemic lupus erythematosus using multiparametric cardiac magnetic resonance imaging.使用多参数心脏磁共振成像评估系统性红斑狼疮患者的亚临床心肌受累情况。
BMC Cardiovasc Disord. 2025 Aug 9;25(1):597. doi: 10.1186/s12872-025-05033-8.
5
A predictive nomogram for intramyocardial hemorrhage in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention based on coronary angiography-derived index of microcirculatory resistance.基于冠状动脉造影衍生的微循环阻力指数的ST段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时心肌内出血的预测列线图。
BMC Cardiovasc Disord. 2025 Aug 7;25(1):584. doi: 10.1186/s12872-025-05057-0.
6
Left atrial and ventricular strain and extracellular volume fraction in patients with paroxysmal and persistent atrial fibrillation.阵发性和持续性心房颤动患者的左心房和心室应变及细胞外容积分数
Int J Cardiovasc Imaging. 2025 Jun 25. doi: 10.1007/s10554-025-03443-5.
7
Establishing Cardiac MRI Reference Ranges Stratified by Sex and Age for Cardiovascular Function during Exercise.建立按性别和年龄分层的运动期间心血管功能的心脏磁共振成像参考范围。
Radiol Cardiothorac Imaging. 2025 Jun;7(3):e240175. doi: 10.1148/ryct.240175.
8
Highlights of the Society for Cardiovascular Magnetic Resonance 2025 conference: Leading the way to accessible, efficient, and sustainable cardiovascular magnetic resonance.心血管磁共振学会2025年会议亮点：引领通往可及、高效和可持续的心血管磁共振之路。
J Cardiovasc Magn Reson. 2025 May 23;27(2):101914. doi: 10.1016/j.jocmr.2025.101914.
9
Myocardial fibrosis in primary aldosteronism.原发性醛固酮增多症中的心肌纤维化
Front Endocrinol (Lausanne). 2025 May 6;16:1567876. doi: 10.3389/fendo.2025.1567876. eCollection 2025.
10
Accelerated deep learning-based function assessment in cardiovascular magnetic resonance.基于深度学习的心血管磁共振加速功能评估
Radiol Med. 2025 May 17. doi: 10.1007/s11547-025-02019-6.
心脏影像学在安德森-法布里病的诊断和管理中的作用。
JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1230-1242. doi: 10.1016/j.jcmg.2018.11.039.
4
Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.磁共振灌注或冠状动脉疾病的血流储备分数。
N Engl J Med. 2019 Jun 20;380(25):2418-2428. doi: 10.1056/NEJMoa1716734.
5
Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial.螺内酯预处理和早期治疗以最小化 ST 段抬高型心肌梗死再灌注损伤：MINIMIZE STEMI 试验。
Am Heart J. 2019 May;211:60-67. doi: 10.1016/j.ahj.2019.02.005. Epub 2019 Feb 20.
6
Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction.左心室心肌致密化不全患者中晚期钆增强和整体收缩功能障碍的预后作用的荟萃分析。
JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 1):2141-2151. doi: 10.1016/j.jcmg.2018.12.029. Epub 2019 Mar 13.
7
Prognostic Role of CMR and Conventional Risk Factors in Myocardial Infarction With Nonobstructed Coronary Arteries.CMR 和常规危险因素在非阻塞性冠状动脉心肌梗死中的预后作用。
JACC Cardiovasc Imaging. 2019 Oct;12(10):1973-1982. doi: 10.1016/j.jcmg.2018.12.023. Epub 2019 Feb 13.
8
Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy.致心律失常性右室心肌病的猝死和左室受累。
Circulation. 2019 Apr 9;139(15):1786-1797. doi: 10.1161/CIRCULATIONAHA.118.037230.
9
Diagnostic performance of contrast-enhanced and unenhanced combined pulmonary artery MRI and magnetic resonance venography techniques in the diagnosis of venous thromboembolism.对比增强与非增强联合肺动脉磁共振成像及磁共振静脉血管造影技术在静脉血栓栓塞症诊断中的诊断性能
Br J Radiol. 2019 Mar;92(1095):20180695. doi: 10.1259/bjr.20180695. Epub 2019 Jan 10.
10
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018年美国心脏协会/美国心脏病学会成人先天性心脏病管理指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Apr 2;139(14):e637-e697. doi: 10.1161/CIR.0000000000000602.